By Michael Vlessides
Vancouver, British Columbia—A team of Ohio researchers found that a novel formulation of extended-release (ER) morphine sulfate MorphaBond ER (Daiichi Sankyo, Inspirion Delivery Sciences) is unlikely to be abused via smoking, largely due to a high level of degradation of its active ingredient when burned.
A common route of opioid abuse is via smoking, which is often performed by heating manipulated product in homemade foil pipes, a process known as “chasing the